针灸治疗肠易激综合征的系统评价再评价
该伞形综述纳入15篇针灸治疗肠易激综合征的系统评价,用AMSTAR 2、PRISMA 2020和GRADE评价其方法学、报告和证据质量。多数系统评价认为针灸有益,但方法学质量多为极低,报告质量多有缺陷,证据质量低或极低,需更高质量原始研究和系统评价。
要点
- 多数系统评价提示针灸对肠易激综合征有益。
- 纳入系统评价方法学质量多为极低,报告质量多有缺陷。
- GRADE证据质量普遍为低或极低级别。
核心结论
- 多数纳入系统评价认为针灸对肠易激综合征有益,但系统评价的方法学、报告和证据质量需提高。
研究设计与样本
- 伞形综述,检索8个数据库至2023年2月20日,纳入15篇针灸治疗肠易激综合征的系统评价。
主要发现
- AMSTAR 2评价显示2篇方法学质量低,13篇极低。
- PRISMA 2020评价显示2篇报告质量严重缺陷,12篇有些缺陷,1篇相对完整。
- GRADE评价显示证据质量低或极低。
关键数值与推荐
- AMSTAR 2主要问题包括未注册方案、检索策略不完整、未提供排除研究列表、未充分考虑偏倚风险、未评估发表偏倚。
- PRISMA 2020主要问题包括缺乏完整检索策略、未提供排除研究列表及理由、未进行异质性和敏感性分析、未评估证据可信度、未注册方案。
- GRADE评价证据质量低或极低。
临床怎么用
- 临床可参考多数系统评价的提示,但应知晓其方法学与证据质量普遍不高。
局限性
- 纳入系统评价方法学质量多为极低,报告质量多有缺陷,证据质量低或极低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Irritable bowel syndrome (IBS) is a functional bowel disease characterized by abdominal pain or discomfort associated with altered bowel habits. Several clinical studies have demonstrated the effectiveness of acupuncture and moxibustion for IBS. Many systematic reviews of acupuncture and moxibustion for IBS have been published in recent years, but their results are not entirely consistent. OBJECTIVE: To evaluate the methodological, reporting, and evidence quality of systematic reviews of acupuncture and moxibustion for IBS. SEARCH STRATEGY: Systematic reviews of acupuncture and moxibustion for IBS published before February 20, 2023 were searched in eight databases: PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure, Wanfang Data, VIP Database for Chinese Technical Periodicals, and China Biology Medicine. The keywords used for literature search were acupuncture, moxibustion, systematic review, meta-analysis, and irritable bowel syndrome. INCLUSION CRITERIA: Systematic reviews and meta-analyses of randomized controlled trials of acupuncture and moxibustion for IBS were included. DATA EXTRACTION AND ANALYSIS: Relevant information was independently extracted by two investigators. The A MeaSurement Tool to Assess systematic Reviews 2 (AMSTAR 2), Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020), and Grading of Recommendations Assessment, Development and Evaluation (GRADE) were used to evaluate the methodological quality, reporting quality and evidence quality, respectively. RESULTS: A total of 342 studies were retrieved and 15 systematic reviews were included. The results of AMSTAR 2 showed low methodological quality in 2 studies and very low methodological quality in the remaining 13 studies, with main issues being failure to register a protocol, incomplete search strategy, not providing a list of excluded studies, incomplete consideration of the risk of bias in the included studies, and a failure to assess the publication bias. The results of PRISMA 2020 showed seriously deficient reporting quality of 2 studies, somewhat deficient reporting quality of 12 studies, and relatively complete reporting quality of 1 study, with the main problems being lack of a complete search strategy, non-availability of a list of excluded studies with justification for their exclusion, not conducting heterogeneity and sensitivity analyses, not evaluating the credibility of the evidence, and not registering the protocol. The results of GRADE showed that the quality of the evidence is low or very low. CONCLUSION: Most included systematic reviews interpreted findings to suggest that acupuncture and moxibustion have benefits for IBS. However, there is a need to improve the methodological, reporting and evidence quality of the systematic reviews. Larger, multicenter, rigorously designed randomized controlled trials and high-quality systematic reviews are required to obtain more robust evidence. PLEASE CITE THIS ARTICLE AS: Ma YY, Hao Z, Chen ZY, Shen YX, Liu HR, Wu HG, Bao CH. Acupuncture and moxibustion for irritable bowel syndrome: An umbrella systematic review. J Integr Med. 2024; 22(1): 22-31.
引用
- Ma YY, Hao Z, Chen ZY, et al. Acupuncture and moxibustion for irritable bowel syndrome: An umbrella systematic review. J Integr Med. 2023. PMID: 38199885. doi:10.1016/j.joim.2023.12.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。